Inspire Medical Systems Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名54/206位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價130.32。中期看,股價處於上升通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
Inspire Medical Systems Inc評分
相關信息
行業排名
54 / 206
全市場排名
140 / 4562
所屬行業
醫療設備與耗材
壓力支撐
由於公司未披露,未能獲取相關數據
多維評測
本期評分
上期評分
分析師目標
基於
20
分析師
買入
評級
130.322
目標均價
-9.49%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議
Inspire Medical Systems Inc亮點
亮點風險
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
公司代碼INSP
公司Inspire Medical Systems Inc
CEOHerbert (Timothy P)
網址https://www.inspiresleep.com/
常見問題
Inspire Medical Systems Inc(INSP)的當前股價是多少?
Inspire Medical Systems Inc(INSP)的當前股價是 95.390。
Inspire Medical Systems Inc 的股票代碼是什麼?
Inspire Medical Systems Inc的股票代碼是INSP。
Inspire Medical Systems Inc股票的52週最高點是多少?
Inspire Medical Systems Inc股票的52週最高點是216.010。
Inspire Medical Systems Inc股票的52週最低點是多少?
Inspire Medical Systems Inc股票的52週最低點是70.770。
Inspire Medical Systems Inc的市值是多少?
Inspire Medical Systems Inc的市值是2.77B。
Inspire Medical Systems Inc的淨利潤是多少?
Inspire Medical Systems Inc的淨利潤為53.51M。
現在Inspire Medical Systems Inc(INSP)的股票是買入、持有還是賣出?
根據分析師評級,Inspire Medical Systems Inc(INSP)的總體評級為買入,目標價格為130.322。
Inspire Medical Systems Inc(INSP)股票的每股收益(EPS TTM)是多少
Inspire Medical Systems Inc(INSP)股票的每股收益(EPS TTM)是1.499。